Browse by Medical Category
Apply for Fellowships at MIND
Apply for Jobs at MIND
View Neurology research centers and labs
The institute was founded by and is directed by Anne B. Young, MD, PhD, formerly Chief of Neurology and Julianne Dorn Professor of Neurology at Harvard Medical School. Laboratories are directed by MD’s, PhD’s and MD/PhD’s who are members of the faculty of Harvard Medical School and have appointments in the Mass General departments of Neurology, Neurosurgery, Psychiatry, and Pathology.
In this uniquely integrated research center, a team of world-renowned experts together with young, innovative researchers collaborate, strategize, and share technology to find treatment for these diseases. As promising leads are developed in one area, they are tested in the other neurodegenerative disorders.
Since many of the laboratories at MIND are led by physician-scientists, translating scientific breakthroughs into drugs and other therapies that will improve the lives of patients is MIND’s core mission.
The MassGeneral Institute for Neurodegenerative Disease’s model of collaboration and sharing of resources will hasten the pace of discovery and, we hope, change the prognosis for these diseases in this generation.
MassGeneral Institute for Neurodegenerative Disease was founded in 2001 with a mission to translate laboratory discoveries into prevention, treatment and cures for Alzheimer’s, ALS, Huntington’s, Parkinson’s and other neurodegenerative diseases. Driven by a sense of urgency due to our nation’s burgeoning aging population, MIND seeks to accelerate therapies that lessen the devastating toll of disease on patients and families.
While the symptoms differ, Alzheimer’s, Parkinson’s, ALS and Huntington’s diseases have characteristics that point to related mechanisms. We can now see that advances in one disease are likely to hold promise for the other disorders. MIND is poised to take advantage of this synergy by encouraging researchers to collaborate, communicate, take risks, and defy conventional thinking.
© 2011 MassGeneral Institute for Neurodegenerative Disease
Back to Top